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AbstrACt
Objective Catheter-related bloodstream infections are 
one of the most important adverse events for patients. 
Evidence-based practice embraces interventions to 
prevent and reduce catheter-related bloodstream 
infections in patients. At present, a growing number of 
guidelines exist worldwide. The purpose of the study 
was to assess clinical practice guidelines for peripheral 
and central venous access device care and prevention of 
related complications.
Design Systematic review of clinical practice guidelines: 
We conducted a search of the literature published from 2005 
to 2018 using Medline/PubMed, Embase, CINAHL, Ovid, 
ScienceDirect, Scopus and Web of Science. We also evaluated 
grey literature sources and websites of organisations that 
compiled or produced guidelines. Guideline quality was 
assessed with the Appraisal of Guidelines for Research 
and Evaluation, Second Edition tool by three independent 
reviewers. Cohen’s kappa coefficient was used to evaluate the 
concordance between reviewers.
results We included seven guidelines in the evaluation. 
The concordance between observers was substantial, 
K=0.6364 (95% CI 0.0247 to 1.2259). We identified seven 
international guidelines, which scored poorly on crucial 
domains such as applicability (medium 39%), stakeholder 
involvement (medium 65%) and methodological rigour 
(medium 67%). Guidelines by Spanish Health Ministry 
and UK National Institute for Health and Care Excellence 
presented the highest quality.
Conclusions It is crucial to critically evaluate the validity 
and reliability of clinical practice guidelines so the best, 
most context-specific document is selected. Such choice 
is a necessary prior step to encourage and support health 
organisations to transfer research results to clinical 
practice. The gaps identified in our study may explain the 
suboptimal clinical impact of guidelines. Such low adoption 
may be mitigated with the use of implementation guides 
accompanying clinical documents.
IntrODuCtIOn 
Vascular access devices (VADs) are the most 
commonly used invasive devices in hospitals 
worldwide.1 These devices expose patients to 
multiple complications related to their inser-
tion, maintenance and management.1 2 Cath-
eter-related bloodstream infections (CRBSIs) 
are one of the adverse events with worst 
impact for patients3 in terms of morbidity 
and mortality.4 CRBSIs account for 40.3% of 
all bloodstream infections, of which are asso-
ciated with the use of central venous cathe-
ters (CVCs) and peripheral venous catheters 
(PVCs).5 The incidence of central line-asso-
ciated bloodstream infections is 5.7 per 1000 
catheter-days,6 and 0.1%, 0.5 per 1000 cathe-
ter-days in PVCs.7 CRBSIs can prolong length 
of hospital stay2 5 and present an attributable 
mortality rate of up to 25%.8 9 The approxi-
mate average cost per episode is US$45 000 
and resulting in US$2.3 billion of unneces-
sary expenditure per year in the USA.3 
Nowadays, health organisations benefit 
from the advances in knowledge about service 
delivery generated by researchers resulting 
in optimal care for patients and citizens. 
The aim of such evidence-based practice is 
strengths and limitations of this study
 ► Methodological quality evaluation of vascular access 
devices clinical guidelines is lacking.
 ► Despite recommendations being based on sub-
jective assessments, evaluators’ concordance us-
ing the  Appraisal of Guidelines for Research and 
Evaluation, Second Edition tool was substantial.
 ► We identified low scores on crucial guideline do-
mains such as applicability, rigour and stakeholder 
involvement.
 ► The gaps identified may explain the suboptimal 
impact of guidelines in practice and the need for 
implementation guides accompanying the clinical 
documents.
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to offer care experiences that are informed by the best 
available scientific knowledge, clinical expertise and user 
preferences.10 11 To assist the decision-making of health 
professionals and patients about appropriate healthcare 
interventions in specific clinical circumstances,12 clin-
ical practice guidelines (CPGs) are developed. These 
CPGs are based on empirical evidence, explicit in their 
methods of development, critically reviewed by experts, 
free of conflicts of interest and with specific and unam-
biguous recommendations.
CPGs are not however exempt from problems.13 In 
recent years, the number of these CPGs has grown dramat-
ically and thus the volume of evidence proven to be 
unmanageable and of variable quality.14 Another concern 
may refer to the inclusion of studies with statistical yet 
marginal or insignificant clinical significance.15 Addition-
ally, there is frequent tardiness in the implementation of 
the recommendations within the CPGs, probably fuelled 
by perceptions of clinical judgement as the main element 
in clinical decision-making.16 These facts can ultimately 
weaken the credibility of CPGs and therefore increase the 
difficulty of their implementation.
To date, few systematic attempts have been made to 
compare the quality of CPGs that provide recommen-
dations for the care and prevention of adverse events 
associated with vascular catheter in adults.17 Therefore, 
the purpose of this study was to assess the quality of 
such CPGs using the Appraisal of Guidelines Research 
and Evaluation, Second Edition (AGREE II) tool18 and 
analyse methodological factors related to the process of 
CPGs development on effective knowledge mobilisation.
Methods
Search strategy
Two researchers (IB-M, MAR-C) conducted the search 
from March to April 2018. Searches were constructed using 
relevant medical subject headings (MeSH): ‘Complica-
tions,’ ‘Catheter-Related Infections,’ ‘Catheter obstruction,’ 
‘Phlebitis,’ ‘Extravasation of Diagnostic and Therapeutic 
Materials,’ ‘Peripheral Catheterization,’ ‘Central Venous 
Catheterization,’ ‘Nursing care,’ ‘Guideline’ and ‘Evidence-
Based Practice’ with variations of keywords terms ‘Adverse 
events’ and ‘Implementation.’ The following databases and 
bibliographic resources were searched: Medline/PubMed, 
Embase, CINAHL, Ovid, ScienceDirect, Scopus and Web of 
Science. We also explored the websites of organisations that 
compile or produce guidelines such as Joanna Briggs Insti-
tute (JBI, Australia), National Health and Medical Research 
Council (NHMRC, Australia), Registered Nurses Associa-
tion of Ontario (RNAO, Canada), The National Institute 
for Health and Care Excellence (NICE, United Kingdom), 
National Guideline Clearinghouse (NGC, US), US Centers 
for Disease Control and Prevention (CDC, US), Scottish 
Intercollegiate Guidelines Network (SIGN, Scotland) and 
Library Clinical Practice Guidelines of the National Health 
Services (GuiaSalud, Spain). In addition, we evaluated grey 
literature available in professional societies and groups 
such as the Infusion Nurses Society. The search considered 
evidence from January 2005 to April 2018 to avoid the 
inclusion of CPGs with outdated recommendations online 
supplementary appendix 1.
Eligibility criteria
We used the definition of CPG developed by the Institute 
of Medicine.12 We selected CPG with recommendations 
developed systematically and including a grading system 
related to the quality of evidence or the strength of the 
recommendations to assist healthcare professionals and 
patients in making decisions about appropriate health-
care, at the prevention of complications, management 
and care on CRBSIs associated with VAD in hospital 
adults. Expert consensus statements and specifics CPGs 
of other pathologies, such as cancer, radiology or renal 
were excluded, as its target population was very specific.
Data management and extraction
IB-M and MAR-C independently conducted the selection 
of studies, with disagreements resolved after discussion 
with a third researcher (JDP-G). The titles and abstracts 
obtained were then scrutinised for selection of CPGs. 
Only full-text studies in English or Spanish were included 
in the review.
IB-M and MAR-C independently extracted the following 
information: lead author, developing organisation, 
country, year of publication, recommendations, quality of 
evidence and strength of recommendations. IB-M devel-
oped a data extraction form based on the domains spec-
ified in the AGREE II instrument for the evaluation of 
CPGs online supplementary appendix 2.18 The extracted 
data were synthesised and similarities and differences 
compared.
We reported our findings in accordance with the 
Preferred Reporting Items for Systematic Reviews and 
Meta-analyses guidelines (PRISMA).19 The documents 
to be evaluated were read randomly by the reviewers, to 
avoid biasing the scores due to familiarity with the previ-
ously evaluated CPGs.20
Data analysis
Three reviewers independently assessed the CPGs using 
the AGREE II instrument.18 This tool use methodological 
quality criteria to examine the variability of quality, rigour 
and transparency used during the development of CPGs. 
IB-M calculated the final quality score according to the 
protocol of the instrument and the scores provided by 
the three reviewers for the items within each domain. In 
addition, a median score and rank was obtained for each 
domain of the instrument. Cohen’s kappa coefficient 
was used to evaluate the concordance between reviewers 
on the item ‘global guide evaluation’. The following 
labels will be assigned to the corresponding ranges of 
kappa: Poor (<0.00), Slight (0.00–0.20), Fair (0.21–0.40), 
Moderate (0.41–0.60), Substantial (0.61–0.80) and almost 
Perfect (0.81–1.00).21 The Epidat V.4.1 software was used 
for statistical analysis.22
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Patient and public involvement
No patients or members of the public were involved in 
the development of the research question, nor the design 
or the conduct of the study, nor the interpretation and 
writing up of results.
results
A total of 1447 citations and abstracts were identified 
through the database search, with eight further CPGs 
obtained from guideline development organisations. 
Duplicates were deleted and excluded. The reviewers also 
discarded six summaries of CPG; a standard of practice 
from the Infusion Nurses Society; a Best Practice Sheet 
of Joanna Briggs Institute; two CPGs for the maintenance 
of intravascular catheters in children; four oncology 
CPGs; one Anaesthesiology CPG; two infusion CPGs; one 
radiology CPG; two nutrition CPGs and two renal CPGs; 
and one older version online supplementary appendix 3. 
The selection process is summarised in the PRISMA flow 
diagram in figure 1.
Seven CPGs were finally included in the synthesis of 
evidence and evaluated with the AGREE II instrument. 
The characteristics of the selected CPGs are presented 
in table 1. The CPGs were developed by National Insti-
tute for Health and Care Excellence,23 Registered Nurses 
Association of Ontario,24 25 Ministry of Health26 (Spain), 
Centres for Disease Control and Prevention/Health-
care Infection Control Practices Advisory Committee,27 
The Society for Healthcare Epidemiology of America/
Infectious Diseases Society of America28 and Department 
of Health of Queensland Government29 (Australia).
The CPGs were published between 2008 and 2014: 
three from 2014,23 26 28 one from 2013,29 one from 201127 
and two from 2008.24 25 There was heterogeneity in the 
objectives of the different documents. For example, the 
epic323 aimed to describe clinically effective measures 
to be used by health professionals in hospital infection 
prevention; however, in three24 25 27 the specified objective 
was the provision of recommendations to professionals 
to help in decision-making about peripheral and central 
venous access. Recommendations for CVC alone were 
detailed in one paper,28 with another focusing only on 
peripherally inserted central catheters.29
Figure 1 The Preferred Reporting for Systematic Reviews and Meta-analyses diagram representing the systematic literature 
search. AGREE II, Appraisal of Guidelines for Research and Evaluation, Second Edition. 
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The scores for each domain evaluated with the AGREE 
II tool are presented in table 2. Domain 1 (‘Scope and 
purpose’) relates to the general scope and purpose of 
the CPGs, specific clinical questions to be addressed and 
target population. The median score was 74% (range 
37%–100%), with five documents scoring above 70%.
The domain 2 (‘Stakeholder involvement’) reflected 
whether the guideline development process included 
input and involvement from appropriate stakeholders. 
The median score obtained was 65% (range 25%–91%), 
with three guidelines scoring above 70%. Additionally, 
the item 5 (‘The views and preferences of the target 
population have been sought’) in the AGREE II instru-
ment received the lowest score.23–26
In terms of ‘Rigour of development’ (domain 3), 
the median score across the category was 67% (range 
9%–87%), with two guidelines scoring above 70%. This 
section focused on the methods in place for gathering 
and synthesising evidence during the development or 
updating of the document. Most guidelines described 
the process of development, but they did so in varying 
levels of detail. We found poor description of the process 
followed to search and review evidence, and only one 
document described the approach to follow regarding 
updates of the information.
The domain 4 (‘Clarity of presentation’) centred on 
how specific and unambiguous the recommendations 
were, including clearly presented options for the manage-
ment of the health condition and with easily identifiable 
key recommendations. This domain was the best evalu-
ated, obtaining a median score of 84% (range 81%–91%), 
and with all CPGs exceeding the 70% score threshold.
‘Applicability criteria’ (domain 5) referred to facil-
itators and barriers to the implementation of recom-
mendations within the guidelines, the strategies for 
implementation of such recommendations and the 
likely resource implications associated. The median 
score obtained by the CPGs on this domain was 39% 
(range 14%–88%) with three above 70%. The CPGs 
were rated negatively as they did not take into account 
possible enabling factors for implementation, strategies 
to improve adoption, resource considerations or avail-
ability of monitoring indicators.
Finally, the domain 6 (‘Editorial independence’) 
aimed to ensure a lack of bias in the development of the 
guideline. The domain was relatively well scored, with a 
median across CPGs of 78% (range 19%–88%) and five 
above 70%. Most CPGs did provide statements regarding 
funding, potential influence on the recommendations 
endorsed or relevant conflicts of interest.
Overall assessment
The average score across the CPGs was moderate 
(median 62%), scores ranged from 38%29 to 90%.26 The 
best results following the global evaluation of the CPGs 
and their recommendations for practice of care were 
obtained by CPGs of the Ministry of Health in Spain,26 
and epic3,23 being strongly recommended. In addition, 
three CPGs24 25 28 have been recommended, which would 
needed modifications on the domains of rigour and appli-
cability28; process of actualisation24 25 and two CPGs27 29 
have not been recommended for use of clinical practice 
(table 2).
Table 1 Characteristics of clinical practice guidelines (CPG)
CPG Organisation Country Year
1 epic3: National Evidence-Based Guidelines for 
Preventing Healthcare-Associated Infections in 
National Health Service Hospitals in England.
National Institute for Health and Care 
Excellence.
UK 2014
2 CPG on intravenous therapy with non-indwelling 
devices in adults.
CPG work group on intravenous 
therapy with non-indwelling devices in 
adults. Ministry of Health.
Spain 2014
3 Strategies to Prevent Central Line–Associated 
Bloodstream Infections in Acute Care Hospitals: 
2014 Update.
Society for Healthcare Epidemiology 
of America/Infectious Diseases Society 
of America.
USA 2014
4 Guideline Peripherally Inserted Central Venous 
Catheter.
Centre for Healthcare Related Infection 
Surveillance and Prevention and 
Tuberculosis Control. Queensland 
Government.
Australia 2013
5 Guidelines for the Prevention of Intravascular 
Catheter-related Infections.
Society for Healthcare Epidemiology 
of America/Infectious Diseases Society 
of America.
USA 2011
6 Care and Maintenance to reduce Vascular Access 
Complications.
Registered Nurses’ Association of 
Ontario (RNAO).
Canada 2008
7 Assessment and Device Selection for Vascular 
Access.
RNAO. Canada 2008
5Blanco-Mavillard I, et al. BMJ Open 2018;8:e021040. doi:10.1136/bmjopen-2017-021040
Open access
Ta
b
le
 2
 
R
es
ul
ts
 o
b
ta
in
ed
 fr
om
 c
lin
ic
al
 p
ra
ct
ic
e 
gu
id
el
in
e 
(C
P
G
) u
si
ng
 t
he
 A
p
p
ra
is
al
 o
f G
ui
d
el
in
es
 fo
r 
R
es
ea
rc
h 
an
d
 E
va
lu
at
io
n,
 S
ec
on
d
 E
d
iti
on
 in
st
ru
m
en
t
C
P
G
 (o
rg
an
is
at
io
n)
S
co
p
e 
(%
)
S
ta
ke
ho
ld
er
 
in
vo
lv
em
en
t 
(%
)
R
ig
o
ur
 (%
)
C
la
ri
ty
 (%
)
A
p
p
lic
ab
ili
ty
 (%
)
In
d
ep
en
d
en
ce
 (%
)
Fi
na
l e
va
lu
at
io
n 
(%
)
R
ec
o
m
m
en
d
ed
1.
 N
at
io
na
l I
ns
tit
ut
e 
fo
r 
H
ea
lth
 a
nd
 C
ar
e 
E
xc
el
le
nc
e
93
91
87
84
39
94
86
Ye
s
2.
 M
in
is
tr
y 
of
 H
ea
lth
, 
S
p
ai
n
10
0
89
87
91
81
86
90
Ye
s
3.
 C
en
te
rs
 fo
r 
D
is
ea
se
 C
on
tr
ol
 
an
d
 P
re
ve
nt
io
n/
H
ea
lth
ca
re
 In
fe
ct
io
n 
C
on
tr
ol
 P
ra
ct
ic
es
 
A
d
vi
so
ry
 C
om
m
itt
ee
74
44
22
82
32
69
48
N
o
4.
 Q
ue
en
sl
an
d
 
G
ov
er
nm
en
t
37
25
9
81
14
19
38
N
o
5.
 S
oc
ie
ty
 fo
r 
H
ea
lth
ca
re
 
E
p
id
em
io
lo
gy
 o
f 
A
m
er
ic
a/
In
fe
ct
io
us
 
D
is
ea
se
s 
S
oc
ie
ty
 o
f 
A
m
er
ic
a
70
49
28
84
39
75
67
Ye
s,
 w
ith
 m
od
ifi
ca
tio
n
6.
 R
eg
is
te
re
d
 N
ur
se
s 
A
ss
oc
ia
tio
n 
of
 
O
nt
ar
io
 (R
N
A
O
)
60
65
67
91
88
83
57
Ye
s,
 w
ith
 m
od
ifi
ca
tio
n
7.
 R
N
A
O
74
72
69
91
85
78
62
Ye
s,
 w
ith
 m
od
ifi
ca
tio
n
M
ed
ia
n 
(r
an
ge
)
74
 (3
7–
10
0)
65
 (2
5–
91
)
67
 (9
–8
7)
84
 (8
1–
91
)
39
 (1
4–
88
)
78
 (1
9–
88
)
62
 (3
8–
90
)
6 Blanco-Mavillard I, et al. BMJ Open 2018;8:e021040. doi:10.1136/bmjopen-2017-021040
Open access 
Agreement among reviewers
The agreement among the three independent reviewers is 
presented in table 3. The overall agreement was substan-
tial (K=0.6364; 95% CI 0.0247 to 1.2259), with perfect 
intracategory concordance (K=1.0) for guidelines classi-
fied as ‘recommendable’. The evaluators demonstrated 
a moderate agreement (K=0.5556) for those guides 
classified as ‘recommendable with modifications’ coin-
ciding with a moderate quality of evaluation. However, 
the agreement was small (K=0.2) when the quality of the 
documents was low and their use in clinical practice was 
not recommended.
DIsCussIOn
Our study focused on international CPGs aimed at facili-
tating the management and care of VAD and preventing 
complications associated on CRBSIs with their use in 
adults. We compared the quality of existing guides using 
the AGREE II tool and analysed relevant methodological 
factors related to the process of guideline development. 
Many of the CPGs included in this study scored highly 
in some, but not all, domains. Overall, the quality of the 
CPGs examined was moderate. More than 70% of these 
presented specific and well-described recommendations 
including different options for clinical management, 
specific objectives, health aspects to be addressed and 
the target population. The best scores were received by 
the domains ‘Clarity of presentation’ and ‘Scope and 
objective’.
However, we identified low scores on other equally 
crucial domains for effective implementation including 
‘stakeholder involvement’, ‘methodological rigour’ and 
applicability’. These findings are consistent with other 
studies of similar methodology.20 30 Regarding stake-
holder involvement, the guidelines did not report on 
whether the views of patients or users were sought during 
the process of guideline development. Such absence may 
be due to a number of factors including lack of recog-
nition and value of the perceptions of the main actors 
targeted by the guides.13 CPGs tend to centralise knowl-
edge from experts without the consideration of patient 
or user involvement in guideline development, assuming 
that the patients’ care may have a less active role.31–33
In terms of methodological rigour, the evidence 
suggests that the quality and accuracy of CPG elabora-
tion can be highly variable,34 even when dealing with the 
same subject. These low scores may be due to excessively 
rigorous criteria for the inclusion of clinical trials based 
on organisational or behavioural interventions. CPGs 
evaluated offer little or no information on the strengths 
and limitations of the evidence used, or the approach and 
timing of updates or consideration of emerging evidence.
Finally, a lack of consideration towards applicability 
criteria may hamper the implementation of guideline 
recommendations in clinical practice, this aspect is 
as important as the methodological rigour and stake-
holder involvement in effective knowledge mobilisation. 
Currently, there is a fundamental problem that may be 
influencing the difficulty of implementing recommen-
dations. CPGs only include studies that provide results 
about what needs to be done and are collected in the best 
available evidence. However, the use of realist revisions on 
what has worked, and for whom could help in optimising 
the implementation process.35 In the last decade, we have 
observed the growth in the volume of evidence to be 
appraised to a point of unmanageability, especially clin-
ical guidelines, obfuscating evidence integration.14 Some 
CPGs include studies with statistically significant benefits, 
but which may be marginal in clinical practice.13 Ulti-
mately, the low scores in the domains referred along with 
the issues cited above may explain the low applicability 
of guidelines and the reported low adherence of recom-
mendations across many clinical areas and settings.36
Clinical implementation is a complex, multifaceted 
phenomenon37 which requires a deep understanding of 
decision-making processes and active strategies within 
organisations.38 Such strategies ought to incorporate 
mechanisms to influence how tacit and explicit knowl-
edge is constructed and internalised in routine practice.39 
Decision-making is not only achieved through a careful 
selection of information based on a defined evaluation 
of possible outcomes40 but depends as much on multiple 
human factors. Scientific evidence should receive signif-
icant, but not necessarily predominant, attention since 
optimal decisions would require the integration of such 
best evidence with clinical expertise together with the 
preferences of users,10 41 leading to the development and 
Table 3 Kappa concordance index among observers for recommendation of CPGs
Concordance index between three observers with three categories
Category Kappa 95% CI Statistic Z P values
Category 1
(recommended)
1 1 1 4.2426 0.0000
Category 2
(recommended, with modifications)
0.5556 −0.2392 1.3199 2.3570 0.0184
Category 3
(not recommended)
0.2 −0.6512 0.9906 0.8485 0.3961
Global kappa 0.6364 0.0247 1.2259 3.6282 0.0003
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use of ‘mindlines’.16 39 42 Further, knowledge transfer must 
be guided by conceptual models that articulate proposed 
strategies to effect behavioural change and the factors 
that may influence adoption of best clinical practice. At 
present, models of proven efficiency43–47 have been instru-
mental to translate the results produced by evidence 
syntheses onto the necessary adherence by professionals, 
thus facilitating dynamics of knowledge transfer and 
mobilisation.48 We endorse the need to supplement 
CPG with implementation guides that facilitate and 
ensure effective implementation process to fidelity the 
best available evidence. We endorse the need to supple-
ment CPG with implementation guides that facilitate and 
ensure effective implementation process to fidelity the 
best available evidence, including result indicators asso-
ciated with prevention and control of infections related 
to VAD.49 50 Likewise, the identification of barriers and 
constraints at institutional and individual level should be 
the first step,51 for the inclusion of strategies that promote 
fidelity52 to recommendations through multicomponent 
and multimodal interventions53 54 formed by facilitation 
of evidence,46 55 the use of e-learning in health profes-
sionals56 and health information of the users.57 These 
multimodal interventions may lead to notable improve-
ments in the clinical outcomes of users.2 58
Limitations
This review presents limitations, chiefly related to the 
search process and inclusion criteria of guidelines. 
For example, we excluded guidelines not published in 
English and Spanish. Regarding the quality evaluation 
of the guidelines, the AGREE II instrument, despite its 
validity, does not offer guidance to interpret the results. 
Our criteria for endorsing some guidelines for practice of 
care were based on the global score across all domains, 
being a subjective perception to each evaluator. However, 
we performed a concordance analysis among the evalua-
tors’ findings for the recommendation of the guidelines. 
Further, AGREE II only assesses the quality of guidelines’ 
structure and content but does not delve into the prac-
tical implications or quality of the recommendations.
COnCLusIOns
Our findings indicate that quality of CPGs reviewed for 
the prevention of complications, management and care 
associated with VAD was moderate, being substantial the 
overall agreement among reviewers. There is a need to 
incorporate mechanisms of critical evaluation about the 
validity and reliability of selected guidelines within envi-
ronments of practice, as a prior and essential requisite 
to knowledge mobilisation. The gaps identified with low 
CPG scores in critical domains for knowledge transfer 
may explain the suboptimal clinical impact of guidelines 
on healthcare practice. This is evidenced by the partly 
adherence of healthcare professionals to recommenda-
tions.36 59 We endorse the need to supplement clinical 
practice documents with implementation guides that 
ensure effective implementation.
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